View of EVALUATION OF TREATMENT RESULTS WITH THE BEVACIZUMAB – mFOLFOX6 REGIMEN IN FIRST-LINE TREATMENT FOR STAGE IV COLORECTAL CANCER PATIENTS

Return to Article Details EVALUATION OF TREATMENT RESULTS WITH THE BEVACIZUMAB – mFOLFOX6 REGIMEN IN FIRST-LINE TREATMENT FOR STAGE IV COLORECTAL CANCER PATIENTS Download Download PDF